Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$195,000.00
Jun 11, 2026
Government
ISO 50001 ENERGY MANAGEMENT SYSTEM IMPLEMENTATION
26-08-B-ISO
This project is to improve energy efficiency in Canada's commercial/institutional building sector.
$99,700.00
Jan 26, 2026
Other
2526-HQ-000156
2526-HQ-000156
To support the protection and improvement of human health and well-being in Canada from the impacts of indoor radon exposure.
$2,199,497.00
Dec 20, 2024
Other
2425-HQ-000098
2425-HQ-000098
To strengthen responses to drug and substance use issues in Canada.
$996,000.00
Dec 18, 2024
Other
2425-HQ-000107
2425-HQ-000107
To protect and improve the health of Canadians in a changing climate, through better understanding of risks and successful adaptations, and building capacity to address and implement them.
$1,456,132.00
Dec 13, 2024
Other
2425-HQ-000096
2425-HQ-000096
To strengthen responses to drug and substance use issues in Canada.
$1,453,903.00
Dec 13, 2024
Other
2425-HQ-000097
2425-HQ-000097
To strengthen responses to drug and substance use issues in Canada.
$1,483,903.00
Dec 13, 2024
Other
2425-HQ-000097
2425-HQ-000097
To strengthen responses to drug and substance use issues in Canada.
$1,583,103.00
Dec 13, 2024
Other
2425-HQ-000097
2425-HQ-000097
To strengthen responses to drug and substance use issues in Canada.
$483,820.00
Oct 20, 2024
Not-for-profit organization or charity
Breaking the solid tumour barrier with mesothelin-specific CAR-T cells and engineered cytokine signaling to enable effective, safe and affordable cancer therapy.
1020483
Immunotherapy has yielded disappointing results against ovarian cancer, prompting the need for bold new approaches. Chimeric Antigen Receptor (CAR) T cells have proven phenomenally successful against blood cancers but show poor efficacy against solid tumours. The NRC has created a nanobody-based, mesothelin-specific CAR (MesoCAR) to treat ovarian, pancreatic and other cancers. With Innovakine Therapeutics, the PI has developed an engineered cytokine receptor system that enables potent, clinician-controlled amplification of T cell responses in vivo. It is proposed to combine these technologies to create a Canadian-made CAR-T cell product that is safe, effective and affordable for the treatment of ovarian cancer. The project will engage in pre-clinical studies to assess the efficacy, safety and mechanistic features of this innovative therapeutic strategy and to develop cost-effective manufacturing methods for future clinical use. The project team is well-positioned to advance this world-first approach to early-stage, near-term clinical trials for the benefit of ovarian cancer patients.
$1,463,062.00
Oct 13, 2024
Other
2425-HQ-000096
2425-HQ-000096
To strengthen responses to drug and substance use issues in Canada.